Marine-derived quorum-sensing inhibitory activities enhance the antibacterial efficacy of tobramycin against Pseudomonas aeruginosa

Marine Drugs

Volumn 13, Issue 1, 2015, Pages

  Busetti, Alessandro ^a   Shaw, George ^a   Megaw, Julianne ^a   Gorman, Sean P ^a   Maggs, Christine A ^b   Gilmore, Brendan F ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b Medical Biology Centre   (United Kingdom)

Author keywords

Antibiotic resistance; Antimicrobial synergy; Biofilm; Marine bacteria; Marine biodiscovery; Pseudomonas aeruginosa; Quorum sensing inhibitors; Tobramycin

Indexed keywords

N ACYLHOMOSERINE LACTONE; PYOCYANINE; PYOVERDINE; TOBRAMYCIN; ANTIINFECTIVE AGENT; SEA WATER;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATE; BIOFILM; CHROMOBACTERIUM VIOLACEUM; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG SCREENING; ENZYME DEGRADATION; ENZYME INACTIVATION; IN VITRO STUDY; MICROBIAL BIOMASS; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM BIOFILM ERADICATION CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; QUORUM SENSING; SIGNAL TRANSDUCTION; CHEMISTRY; CHROMOBACTERIUM; DRUG EFFECTS; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PSEUDOALTEROMONAS;

BACTERIA (MICROORGANISMS); CHROMOBACTERIUM VIOLACEUM ATCC 12472; EUKARYOTA; PSEUDOALTEROMONAS SP.; PSEUDOMONAS AERUGINOSA;

ANTI-BACTERIAL AGENTS; BIOFILMS; CHROMOBACTERIUM; MICROBIAL SENSITIVITY TESTS; PSEUDOALTEROMONAS; PSEUDOMONAS AERUGINOSA; QUORUM SENSING; SEAWATER; TOBRAMYCIN;

EID: 84921646237     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md13010001     Document Type: Article

References (88)

1. D'Costa, V.M.; King, C.E.; Kalan, L.; Morar, M.; Sung, W.W.; Schwarz, C.; Froese, D.; Zazula, G.; Calmels, F.; Debruyne, R; et al. Antibiotic resistance is ancient. Nature 2011, 477, 457-461.
2. Pendleton, J.N.; Gorman, S.P.; Gilmore, B.F. Clinical relevance of the ESKAPE pathogens. Expert Rev. Anti-Infect. Ther. 2013, 11, 297-308.
3. Wellington, E.M.; Boxall, A.B.; Cross, P.; Feil, E.J.; Gaze, W.H.; Hawkey, P.M.; Johnson-Rollings, A.S.; Jones, D.L.; Lee, N.M.; Otten, W.; et al. The role of the natural environment in the emergence of antibiotic resistance in Gram-negative bacteria. Lancet Infect. Dis. 2013, 13, 155-165.
4. Fleming, A. On the antibacterial action of cultures of a Penicillium, with special reference to their use in the isolation of B. influenzae . 1929. Bull. World Health Organ. 2001, 79, 780-790.
5. Fromm, S.; Beisswanger, E.; Kasbohrer, A.; Tenhagen, B.A. Risk factors for MRSA in fattening pig herds-A meta-analysis using pooled data. Prev. Vet. Med. 2014, doi:10.1016/ j.prevetmed.2014.08.014.
6. Klevens, R.M.; Edwards, J.R.; Tenover, F.C.; McDonald, L.C.; Horan, T.; Gaynes, R.; National nosocomial infections surveillance system. Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin. Infect. Dis. 2006, 42, 389-391.
7. Boucher, H.W.; Corey, G.R. Epidemiology of methicillin-resistant Staphylococcus aureus. Clin. Infect. Dis. 2008, 46, S344-S349.
8. Hawkey, P.M. The growing burden of antimicrobial resistance. J. Antimicrob. Chemother. 2008, 62, i1-i9.
9. Boucher, H.W.; Talbot, G.H.; Bradley, J.S.; Edwards, J.E.; Gilbert, D.; Rice, L.B.; Scheld, M.; Spellberg, B.; Bartlett, J. Bad bugs, no drugs: no ESKAPE! An update from the infectious diseases society of America. Clin. Infect. Dis. 2009, 48, 1-12.
10. Talbot, G.H.; Bradley, J.; Edwards, J.E., Jr.; Gilbert, D.; Scheld, M.; Bartlett, J.G. Antimicrobial availability task force of the infectious diseases society of America. Bad bugs need drugs: An update on the development pipeline from the antimicrobial availability task force of the infectious diseases society of America. Clin. Infect. Dis. 2006, 42, 657-668.
11. Fuqua, W.C.; Winans, S.C.; Greenberg, E.P. Quorum sensing in bacteria: The LuxR-LuxI family of cell density-responsive transcriptional regulators. J. Bacteriol. 1994, 176, 269-275.
12. Daniels, R.; Vanderleyden, J.; Michiels, J. Quorum sensing and swarming migration in bacteria. FEMS Microbiol. Rev. 2004, 28, 261-289.
13. Miller, M.B.; Bassler, B.L. Quorum sensing in bacteria. Annu. Rev. Microbiol. 2001, 55, 165-199.
14. Gurich, N.; Gonzalez, J.E. Role of quorum sensing in Sinorhizobium meliloti -alfalfa symbiosis. J. Bacteriol. 2009, 191, 4372-4382.
15. Hentzer, M.; Wu, H.; Andersen, J.B.; Riedel, K.; Rasmussen, T.B.; Bagge, N.; Kumar, N.; Schembri, M.A.; Song, Z.; Kristoffersen, P.; et al. Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors. EMBO J. 2003, 22, 3803-3815.
16. Li, Y.H.; Tang, N.; Aspiras, M.B.; Lau, P.C.; Lee, J.H.; Ellen, R.P.; Cvitkovitch, D.G. A quorum-sensing signaling system essential for genetic competence in Streptococcus mutans is involved in biofilm formation. J. Bacteriol. 2002, 184, 2699-2708.
17. Dunstall, G.; Rowe, M.T.; Wisdom, G.B.; Kilpatrick, D. Effect of quorum sensing agents on the growth kinetics of Pseudomonas spp. of raw milk origin. J. Dairy Res. 2005, 72, 276-280.
18. De Kievit, T.R.; Iglewski, B.H. Bacterial quorum sensing in pathogenic relationships. Infect. Immun. 2000, 68, 4839-4849.
19. Li, J.; Chen, J.; Vidal, J.E.; McClane, B.A. The Agr-like quorum-sensing system regulates sporulation and production of enterotoxin and beta2 toxin by Clostridium perfringens Type A non-food-borne human gastrointestinal disease strain F5603. Infect. Immun. 2011, 79, 2451-2459.
20. Fineran, P.C.; Slater, H.; Everson, L.; Hughes, K.; Salmond, G.P. Biosynthesis of tripyrrole and beta-lactam secondary metabolites in Serratia: integration of quorum sensing with multiple new regulatory components in the control of prodigiosin and carbapenem antibiotic production. Mol. Microbiol. 2005, 56, 1495-1517.
21. Hammer, B.K.; Bassler, B.L. Quorum sensing controls biofilm formation in Vibrio cholerae. Mol. Microbiol. 2003, 50, 101-104.
22. Waters, C.M.; Lu, W.; Rabinowitz, J.D.; Bassler, B.L. Quorum sensing controls biofilm formation in Vibrio cholerae through modulation of cyclic di-gmp levels and repression of vpst. J. Bacteriol. 2008, 190, 2527-2536.
23. Darch, S.E.; West, S.A.; Winzer, K.; Diggle, S.P. Density-dependent fitness benefits in quorum-sensing bacterial populations. Proc. Natl. Acad. Sci. USA 2012, 109, 8259-8263.
24. Rasmussen, T.B.; Givskov, M. Quorum-sensing inhibitors as anti-pathogenic drugs. Int. J. Med. Microbiol. 2006, 296, 149-161.
25. Reimmann, C.; Ginet, N.; Michel, L.; Keel, C.; Michaux, P.; Krishnapillai, V.; Zala, M.; Heurlier, K.; Triandafillu, K.; Harms, H.; et al. Genetically programmed autoinducer destruction reduces virulence gene expression and swarming motility in Pseudomonas aeruginosa PAO1. Microbiology 2002, 148, 923-932.
26. Ulrich, R.L. Quorum quenching: enzymatic disruption of N-acylhomoserine lactone-mediated bacterial communication in Burkholderia thailandensis. Appl. Environ. Microbiol. 2004, 70, 6173-6180.
27. Wopperer, J.; Cardona, S.T.; Huber, B.; Jacobi, C.A.; Valvano, M.A.; Eberl, L. A quorum-quenching approach to investigate the conservation of quorum-sensing-regulated functions within the Burkholderia cepacia complex. Appl. Environ. Microbiol. 2006, 72, 1579-1587.
28. Lee, S.J.; Park, S.Y.; Lee, J.J.; Yum, D.Y.; Koo, B.T.; Lee, J.K. Genes encoding the N-acyl homoserine lactone-degrading enzyme are widespread in many subspecies of Bacillus thuringiensis . Appl. Environ. Microbiol. 2002, 68, 3919-3924.
29. Givskov, M.; de Nys, R.; Manefield, M.; Gram, L.; Maximilien, R.; Eberl, L.; Molin, S.; Steinberg, P.D.; Kjelleberg, S. Eukaryotic interference with homoserine lactone-mediated prokaryotic signalling. J. Bacteriol. 1996, 178, 6618-6622.
30. Hentzer, M.; Riedel, K.; Rasmussen, T.B.; Heydorn, A.; Andersen, J.B.; Parsek, M.R.; Rice, S.A.; Eberl, L.; Molin, S.; Hoiby, N.; et al. Inhibition of quorum sensing in pseudomonas aeruginosa biofilm bacteria by a halogenated furanone compound. Microbiology 2002, 148, 87-102.
31. Manefield, M.; Rasmussen, T.B.; Henzter, M.; Andersen, J.B.; Steinberg, P.; Kjelleberg, S.; Givskov, M. Halogenated furanones inhibit quorum sensing through accelerated LuxR turnover. Microbiology 2002, 148, 1119-1127.
32. Camara, M.; Williams, P.; Hardman, A. Controlling infection by tuning in and turning down the volume of bacterial small-talk. Lancet Infect. Dis. 2002, 2, 667-676.
33. Brackman, G.; Celen, S.; Hillaert, U.; van Calenbergh, S.; Cos, P.; Maes, L.; Nelis, H.J.; Coenye, T. Structure-activity relationship of cinnamaldehyde analogs as inhibitors of AI-2 based quorum sensing and their effect on virulence of Vibrio spp. PLoS One 2011, 6, e16084.
34. Mellbye, B.; Schuster, M. The sociomicrobiology of antivirulence drug resistance: A proof of concept. MBio 2011, 2, doi:10.1128/mBio.00131-11.
35. Shih, P.C.; Huang, C.T. Effects of quorum-sensing deficiency on Pseudomonas aeruginosa biofilm formation and antibiotic resistance. J. Antimicrob. Chemother. 2002, 49, 309-314.
36. Bjarnsholt, T.; Jensen, P.O.; Rasmussen, T.B.; Christophersen, L.; Calum, H.; Hentzer, M.; Hougen, H.P.; Rygaard, J.; Moser, C.; Eberl, L.; et al. Garlic blocks quorum sensing and promotes rapid clearing of pulmonary Pseudomonas aeruginosa infections. Microbiology 2005, 151, 3873-3880.
37. Brackman, G.; Cos, P.; Maes, L.; Nelis, H.J.; Coenye, T. Quorum sensing inhibitors increase the susceptibility of bacterial biofilms to antibiotics in vitro and in vivo. Antimicrob. Agents Chemother. 2011, 55, 2655-2661.
38. Sperandio, V. Novel approaches to bacterial infection therapy by interfering with bacteria-to-bacteria signaling. Exp. Rev. Anti-Infect. Ther. 2007, 5, 271-276.
39. Defoirdt, T.; Boon, N.; Bossier, P. Can bacteria evolve resistance to quorum sensing disruption? PLoS Pathog. 2010, 6, e1000989.
40. Cornaglia, G.; Mazzariol, A.; Lauretti, L.; Rossolini, G.M.; Fontana, R. Hospital outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-1, a novel transferable metallo-beta-lactamase. Clin. Infect. Dis. 2000, 31, 1119-1125.
41. Singh, V.; Arora, V.; Alam, M.J.; Garey, K.W. Inhibition of biofilm formation by esomeprazole in Pseudomonas aeruginosa and Staphylococcus aureus. Antimicrob. Agents Chemother. 2012, 56, 4360-4364.
42. Kukavica-Ibrulj, I.; Bragonzi, A.; Paroni, M.; Winstanley, C.; Sanschagrin, F.; O'Toole, G.A.; Levesque, R.C. In vivo growth of Pseudomonas aeruginosa strains PAO1 and PA14 and the hypervirulent strain LESB58 in a rat model of chronic lung infection. J. Bacteriol. 2008, 190, 2804-2813.
43. Hoiby, N.; Ciofu, O.; Bjarnsholt, T. Pseudomonas aeruginosa biofilms in cystic fibrosis. Future Microbiol. 2010, 5, 1663-1674.
44. Swift, S.; Downie, J.A.; Whitehead, N.A.; Barnard, A.M.; Salmond, G.P.; Williams, P. Quorum sensing as a population-density-dependent determinant of bacterial physiology. Adv. Microb. Physiol. 2001, 45, 199-270.
45. Popat, R.; Crusz, S.A.; Diggle, S.P. The social behaviours of bacterial pathogens. Br. Med. Bull. 2008, 87, 63-75.
46. Schuster, M.; Lostroh, C.P.; Ogi, T.; Greenberg, E.P. Identification, timing, and signal specificity of Pseudomonas aeruginosa quorum-controlled genes: A transcriptome analysis. J. Bacteriol. 2003, 185, 2066-2079.
47. Parsek, M.R.; Greenberg, E.P. Sociomicrobiology: the connections between quorum sensing and biofilms. Trends Microbiol. 2005, 13, 27-33.
48. Dang, H.; Lovell, C.R. Bacterial primary colonization and early succession on surfaces in marine waters as determined by amplified rrna gene restriction analysis and sequence analysis of 16s rrna genes. Appl. Environ. Microbiol. 2000, 66, 467-475.
49. Dobretsov, S.; Teplitski, M.; Bayer, M.; Gunasekera, S.; Proksch, P.; Paul, V.J. Inhibition of marine biofouling by bacterial quorum sensing inhibitors. Biofouling 2011, 27, 893-905.
50. McClean, K.H.; Winson, M.K.; Fish, L.; Taylor, A.; Chhabra, S.R.; Camara, M.; Daykin, M.; Lamb, J.H.; Swift, S.; Bycroft, B.W.; et al. Quorum sensing and Chromobacterium violaceum: Exploitation of violacein production and inhibition for the detection of N-acylhomoserine lactones. Microbiology 1997, 143, 3703-3711.
51. Suga, H.; Smith, K.M. Molecular mechanisms of bacterial quorum sensing as a new drug target. Curr. Opin. Chem. Biol. 2003, 7, 586-591.
52. Throup, J.P.; Camara, M.; Briggs, G.S.; Winson, M.K.; Chhabra, S.R.; Bycroft, B.W.; Williams, P.; Stewart, G.S. Characterisation of the yenI/yenR Locus from Yersinia enterocolitica mediating the synthesis of two N- acylhomoserine lactone signal molecules. Mol. Microbiol. 1995, 17, 345-356.
53. Fletcher, M.P.; Diggle, S.P.; Camara, M.; Williams, P. Biosensor-based assays for PQS, HHQ and related 2-alkyl-4-quinolone quorum sensing signal molecules. Nat. Protoc. 2007, 2, 1254-1262.
54. Poulter, S.; Carlton, T.M.; Su, X.; Spring, D.R.; Salmond, G.P. Engineering of new prodigiosin-based biosensors of Serratia for facile detection of short-chain N-acyl homoserine lactone quorum-sensing molecules. Environ. Microbiol. Rep. 2010, 2, 322-328.
55. Winson, M.K.; Camara, M.; Latifi, A.; Foglino, M.; Chhabra, S.R.; Daykin, M.; Bally, M.; Chapon, V.; Salmond, G.P.; Bycroft, B.W. Multiple N-acyl-L-homoserine lactone signal molecules regulate production of virulence determinants and secondary metabolites in Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. USA 1995, 92, 9427-9431.
56. Stintzi, A.; Evans, K.; Meyer, J.M.; Poole, K. Quorum-sensing and siderophore biosynthesis in Pseudomonas aeruginosa: las R/lasI mutants exhibit reduced pyoverdine biosynthesis. FEMS Microbiol. Lett. 1998, 166, 341-345.
57. Pesci, E.C.; Milbank, J.B.; Pearson, J.P.; McKnight, S.; Kende, A.S.; Greenberg, E.P.; Iglewski, B.H. Quinolone signaling in the cell-to-cell communication system of Pseudomonas aeruginosa . Proc. Natl. Acad. Sci. USA 1999, 96, 11229-11234.
58. Winzer, K.; Falconer, C.; Garber, N.C.; Diggle, S.P.; Camara, M.; Williams, P. The Pseudomonas aeruginosa lectins PA-IL and PA-IIL are controlled by quorum sensing and by RpoS. J. Bacteriol. 2000, 182, 6401-6411.
59. Kim, H.S.; Park, H.D. Ginger extract inhibits biofilm formation by Pseudomonas aeruginosa PA14. PLoS One 2013, 8, e76106.
60. Flemming, H.C.; Wingender, J. Relevance of microbial extracellular polymeric substances (EPSs)-Part I: Structural and ecological aspects. Water Sci. Technol. 2001, 43, 1-8.
61. Flemming, H.C.; Wingender, J. Relevance of microbial extracellular polymeric substances (EPSs)-Part II: Technical aspects. Water Sci. Technol. 2001, 43, 9-16.
62. Dheilly, A.; Soum-Soutera, E.; Klein, G.L.; Bazire, A.; Compere, C.; Haras, D.; Dufour, A. Antibiofilm activity of the marine bacterium Pseudoalteromonas sp. strain 3J6. Appl. Environ. Microbiol. 2010, 76, 3452-3461.
63. James, S.G.; Holmstrom, C.; Kjelleberg, S. Purification and characterization of a novel antibacterial protein from the marine bacterium D2. Appl. Environ. Microbiol. 1996, 62, 2783-2788.
64. Bowman, J.P. Bioactive compound synthetic capacity and ecological significance of marine bacterial genus Pseudoalteromonas . Mar. Drugs 2007, 5, 220-241.
65. Bayles, K.W. The biological role of death and lysis in biofilm development. Nat. Rev. Microbiol. 2007, 5, 721-726.
66. Mai-Prochnow, A.; Evans, F.; Dalisay-Saludes, D.; Stelzer, S.; Egan, S.; James, S.; Webb, J.S.; Kjelleberg, S. Biofilm development and cell death in the marine bacterium Pseudoalteromonas tunicata. Appl. Environ. Microbiol. 2004, 70, 3232-3238.
67. Mai-Prochnow, A.; Webb, J.S.; Ferrari, B.C.; Kjelleberg, S. Ecological advantages of autolysis during the development and dispersal of Pseudoalteromonas tunicata biofilms. Appl. Environ. Microbiol. 2006, 72, 5414-5420.
68. Costa-Ramos, C.; Rowley, A.F. Effect of extracellular products of Pseudoalteromonas atlantica on the edible crab Cancer pagurus. Appl. Environ. Microbiol. 2004, 70, 729-735.
69. Holmstrom, C.; Kjelleberg, S. Marine Pseudoalteromonas species are associated with higher organisms and produce biologically active extracellular agents. FEMS Microbiol. Ecol. 1999, 30, 285-293.
70. Teasdale, M.E.; Liu, J.; Wallace, J.; Akhlaghi, F.; Rowley, D.C. Secondary metabolites produced by the marine bacterium Halobacillus salinus that inhibit quorum sensing-controlled phenotypes in gram-negative bacteria. Appl. Environ. Microbiol. 2009, 75, 567-572.
71. Kjer, J.; Debbab, A.; Aly, A.H.; Proksch, P. Methods for isolation of marine-derived endophytic fungi and their bioactive secondary products. Nat. Protoc. 2010, 5, 479-490.
72. Williams, P.; Camara, M.; Hardman, A.; Swift, S.; Milton, D.; Hope, V.J.; Winzer, K.; Middleton, B.; Pritchard, D.I.; Bycroft, B.W. Quorum sensing and the population-dependent control of virulence. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 2000, 355, 667-680.
73. Visca, P.; Imperi, F.; Lamont, I.L. Pyoverdine siderophores: From biogenesis to biosignificance. Trends Microbiol. 2007, 15, 22-30.
74. Lamont, I.L.; Konings, A.F.; Reid, D.W. Iron acquisition by Pseudomonas aeruginosa in the lungs of patients with cystic fibrosis. Biometals 2009, 22, 53-60.
75. Hassan, H.M.; Fridovich, I. Mechanism of the antibiotic action pyocyanine. J. Bacteriol. 1980, 141, 156-163.
76. Christensen, L.D.; van Gennip, M.; Jakobsen, T.H.; Alhede, M.; Hougen, H.P.; Hoiby, N.; Bjarnsholt, T.; Givskov, M. Synergistic antibacterial efficacy of early combination treatment with tobramycin and quorum-sensing inhibitors against Pseudomonas aeruginosa in an intraperitoneal foreign-body infection mouse model. J. Antimicrob. Chemother. 2012, 67, 1198-1206.
77. Anderson, C.M.; Haygood, M.G. Alpha-proteobacterial symbionts of marine bryozoans in the genus Watersipora . Appl. Environ. Microbiol. 2007, 73, 303-311.
78. Bauer, A.W.; Kirby, W.M.; Sherris, J.C.; Turck, M. Antibiotic susceptibility testing by a standardized single disk method. Am. J. Clin. Pathol. 1966, 45, 493-496.
79. Assefa, E.; Beyene, F.; Santhanam, A. Effect of temperature and ph on the antimicrobial activity of inhibitory substances produced by lactic acid bacteria isolated from Ergo, an Ethiopian traditional fermented milk. Afr. J. Microbiol. Res . 2008, 2, 229-234.
80. Mushtaq, S.; Warner, M.; Cloke, J.; Afzal-Shah, M.; Livermore, D.M. Performance of the Oxoid M.I.C.Evaluator Strips compared with the Etest assay and BSAC agar dilution. J. Antimicrob. Chemother. 2010, 65, 1702-1711.
81. McLean, R.J.; Pierson, L.S., 3rd; Fuqua, C. A simple screening protocol for the identification of quorum signal antagonists. J. Microbiol. Methods 2004, 58, 351-360.
82. Stepanovic, S.; Vukovic, D.; Dakic, I.; Savic, B.; Svabic-Vlahovic, M. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J. Microbiol. Methods 2000, 40, 175-179.
83. Miles, A.A.; Misra, S.S.; Irwin, J.O. The estimation of the bactericidal power of the blood. J. Hyg. Lond. 1938, 38, 732-749.
84. th ed.; National Committee for Clinical Laboratory Standards: Wayne, PA, USA, 2000.
85. Ceri, H.; Olson, M.E.; Stremick, C.; Read, R.R.; Morck, D.; Buret, A. The Calgary biofilm device: New technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J. Clin. Microbiol. 1999, 37, 1771-1776.
86. Romanowski, K.; Zaborin, A.; Fernandez, H.; Poroyko, V.; Valuckaite, V.; Gerdes, S.; Liu, D.C.; Zaborina, O.Y.; Alverdy, J.C. Prevention of siderophore-mediated gut-derived sepsis due to P. aeruginosa can be achieved without iron provision by maintaining local phosphate abundance: Role of pH. BMC Microbiol. 2011, 11, doi:10.1186/1471-2180-11-212.
87. Fothergill, J.L.; Panagea, S.; Hart, C.A.; Walshaw, M.J.; Pitt, T.L.; Winstanley, C. Widespread pyocyanin over-production among isolates of a cystic fibrosis epidemic strain. BMC Microbiol. 2007, 7, 45.
88. Aloush, V.; Navon-Venezia, S.; Seigman-Igra, Y.; Cabili, S.; Carmeli, Y. Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact. Antimicrob. Agents Chemother. 2006, 50, 43-48.